Filing Details

Accession Number:
0000950170-24-116075
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-10-21 21:46:28
Reporting Period:
2024-10-18
Accepted Time:
2024-10-21 21:46:28
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1531177 Sight Sciences Inc. SGHT Surgical & Medical Instruments & Apparatus (3841) 800625749
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1565950 Matthew Link C/O Sight Sciences, Inc.
4040 Campbell Ave., Suite 100
Menlo Park CA 94025
Chief Commercial Officer No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2024-10-18 20,487 $5.98 685,381 No 4 S Direct
Common Stock Disposition 2024-10-21 21,831 $5.61 663,550 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
Footnotes
  1. Reflects shares of the Issuer's common stock, par value $0.001 per share ("Common Stock"), sold to cover the Reporting Person's tax liability in connection with the vesting of restricted stock units.
  2. Reflects the weighted average price at which the shares of Common Stock were sold. The shares were sold in multiple transactions at prices ranging from $5.86 to $6.075, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  3. Reflects the weighted average price at which the shares of Common Stock were sold. The shares were sold in multiple transactions at prices ranging from $5.50 to $5.94, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.